Normoalbuminuric Renal-Insufficient Diabetic Patients
Normoalbuminuric Renal-Insufficient Diabetic Patients A lower-risk group Vincent Rigalleau , MD, PHD 1 , Catherine Lasseur , MD 2 , Christelle Raffaitin , MD 1 , Marie-Christine Beauvieux , PD, PHD 3 , Nicole Barthe , PD 4 , Philippe Chauveau , MD 2 , Christian Combe , MD, PHD 2 and Henri Gin , MD,...
Uloženo v:
| Vydáno v: | Diabetes care Ročník 30; číslo 8; s. 2034 - 2039 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
American Diabetes Association
01.08.2007
|
| ISSN: | 0149-5992, 1935-5548 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Normoalbuminuric Renal-Insufficient Diabetic Patients
A lower-risk group
Vincent Rigalleau , MD, PHD 1 ,
Catherine Lasseur , MD 2 ,
Christelle Raffaitin , MD 1 ,
Marie-Christine Beauvieux , PD, PHD 3 ,
Nicole Barthe , PD 4 ,
Philippe Chauveau , MD 2 ,
Christian Combe , MD, PHD 2 and
Henri Gin , MD, PHD 1
1 Department of Nutrition-Diabétologie, Hôpital Haut-Lévêque, Pessac, France
2 Department of Nephrologie, Université Victor Segalen-Bordeaux 2, Hôpital Pellegrin, Bordeaux, France
3 Department of Biochimie, Hôpital Haut-Lévêque, Pessac, France
4 Department of Médecine Nucléaire, Hôpital Pellegrin, Bordeaux, France
Address correspondence and reprint requests to Vincent Rigalleau, Nutrition-Diabétologie, Hôpital Haut-Lévêque, Avenue de
Magellan, 33600 Pessac, France. E-mail: vincent.rigalleau{at}wanadoo.fr
Abstract
OBJECTIVE —About 20% of diabetic patients with chronic kidney disease (CKD) detected from the new American Diabetes Association recommendations
(albumin excretion rate >30 mg/24 h or estimated glomerular filtration rate [GFR] <60 ml/min per 1.73 m 2 ) may be normoalbuminuric. Do the characteristics and outcome differ for subjects with and without albuminuria?
RESEARCH DESIGN AND METHODS —A total of 89 patients with diabetes and a modification of diet in renal disease (MDRD) estimated GFR (e-GFR) <60 ml/min
per 1.73 m 2 underwent a 51Cr-EDTA B-isotopic GFR determination and were followed up for 38 ± 11 months.
RESULTS —The mean MDRD e-GFR (41.3 ± 13.1 ml/min per 1.73 m 2 ) did not significantly differ from the i-GFR (45.6 ± 29.7). Of the subjects, 15 (17%) were normoalbuminuric. Their i-GFR
did not differ from the albuminuric rate and from their MDRD e-GFR, although their serum creatinine was lower (122 ± 27 vs.
160 ± 71 μmol/l, P < 0.05): 71% would not have been detected by measuring serum creatinine (sCr) alone. They were less affected by diabetic
retinopathy, and their HDL cholesterol and hemoglobin were higher ( P < 0.05 vs. albuminuric). None of the CKD normoalbuminuric subjects started dialysis (microalbuminuric: 2/36, macroalbuminuric:
10/38) or died (microalbuminuric: 3/36, macroalbuminuric: 7/38) during the follow-up period (log-rank test: P < 0.005 for death or dialysis), and their albumin excretion rate and sCr values were stable after 38 months, whereas the
AER increased in the microalbuminuric patients ( P < 0.05), and the sCr increased in the macroalbuminuric patients ( P < 0.01).
CONCLUSIONS —Although their sCr is usually normal, most of the normoalbuminuric diabetic subjects with CKD according to an MDRD e-GFR
below 60 ml/min per 1.73 m 2 do really have a GFR below 60 ml/min per 1.73 m 2 . However, as expected, because of normoalbuminuria and other favorable characteristics, their risk for CKD progression or
death is lower.
AER, albumin excretion rate
CKD, chronic kidney disease
e-GFR, estimated glomerular filtration rate
GFR, glomerular filtration rate
MDRD, modification of diet in renal disease
Footnotes
Published ahead of print at http://care.diabetesjournals.org on 7 May 2007. DOI: 10.2337/dc07-0140.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
Accepted April 29, 2007.
Received January 23, 2007.
DIABETES CARE |
|---|---|
| AbstractList | Normoalbuminuric Renal-Insufficient Diabetic Patients
A lower-risk group
Vincent Rigalleau , MD, PHD 1 ,
Catherine Lasseur , MD 2 ,
Christelle Raffaitin , MD 1 ,
Marie-Christine Beauvieux , PD, PHD 3 ,
Nicole Barthe , PD 4 ,
Philippe Chauveau , MD 2 ,
Christian Combe , MD, PHD 2 and
Henri Gin , MD, PHD 1
1 Department of Nutrition-Diabétologie, Hôpital Haut-Lévêque, Pessac, France
2 Department of Nephrologie, Université Victor Segalen-Bordeaux 2, Hôpital Pellegrin, Bordeaux, France
3 Department of Biochimie, Hôpital Haut-Lévêque, Pessac, France
4 Department of Médecine Nucléaire, Hôpital Pellegrin, Bordeaux, France
Address correspondence and reprint requests to Vincent Rigalleau, Nutrition-Diabétologie, Hôpital Haut-Lévêque, Avenue de
Magellan, 33600 Pessac, France. E-mail: vincent.rigalleau{at}wanadoo.fr
Abstract
OBJECTIVE —About 20% of diabetic patients with chronic kidney disease (CKD) detected from the new American Diabetes Association recommendations
(albumin excretion rate >30 mg/24 h or estimated glomerular filtration rate [GFR] <60 ml/min per 1.73 m 2 ) may be normoalbuminuric. Do the characteristics and outcome differ for subjects with and without albuminuria?
RESEARCH DESIGN AND METHODS —A total of 89 patients with diabetes and a modification of diet in renal disease (MDRD) estimated GFR (e-GFR) <60 ml/min
per 1.73 m 2 underwent a 51Cr-EDTA B-isotopic GFR determination and were followed up for 38 ± 11 months.
RESULTS —The mean MDRD e-GFR (41.3 ± 13.1 ml/min per 1.73 m 2 ) did not significantly differ from the i-GFR (45.6 ± 29.7). Of the subjects, 15 (17%) were normoalbuminuric. Their i-GFR
did not differ from the albuminuric rate and from their MDRD e-GFR, although their serum creatinine was lower (122 ± 27 vs.
160 ± 71 μmol/l, P < 0.05): 71% would not have been detected by measuring serum creatinine (sCr) alone. They were less affected by diabetic
retinopathy, and their HDL cholesterol and hemoglobin were higher ( P < 0.05 vs. albuminuric). None of the CKD normoalbuminuric subjects started dialysis (microalbuminuric: 2/36, macroalbuminuric:
10/38) or died (microalbuminuric: 3/36, macroalbuminuric: 7/38) during the follow-up period (log-rank test: P < 0.005 for death or dialysis), and their albumin excretion rate and sCr values were stable after 38 months, whereas the
AER increased in the microalbuminuric patients ( P < 0.05), and the sCr increased in the macroalbuminuric patients ( P < 0.01).
CONCLUSIONS —Although their sCr is usually normal, most of the normoalbuminuric diabetic subjects with CKD according to an MDRD e-GFR
below 60 ml/min per 1.73 m 2 do really have a GFR below 60 ml/min per 1.73 m 2 . However, as expected, because of normoalbuminuria and other favorable characteristics, their risk for CKD progression or
death is lower.
AER, albumin excretion rate
CKD, chronic kidney disease
e-GFR, estimated glomerular filtration rate
GFR, glomerular filtration rate
MDRD, modification of diet in renal disease
Footnotes
Published ahead of print at http://care.diabetesjournals.org on 7 May 2007. DOI: 10.2337/dc07-0140.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
Accepted April 29, 2007.
Received January 23, 2007.
DIABETES CARE OBJECTIVE—About 20% of diabetic patients with chronic kidney disease (CKD) detected from the new American Diabetes Association recommendations (albumin excretion rate >30 mg/24 h or estimated glomerular filtration rate [GFR] <60 ml/min per 1.73 m2) may be normoalbuminuric. Do the characteristics and outcome differ for subjects with and without albuminuria? RESEARCH DESIGN AND METHODS—A total of 89 patients with diabetes and a modification of diet in renal disease (MDRD) estimated GFR (e-GFR) <60 ml/min per 1.73 m2 underwent a 51Cr-EDTA B-isotopic GFR determination and were followed up for 38 ± 11 months. RESULTS—The mean MDRD e-GFR (41.3 ± 13.1 ml/min per 1.73 m2) did not significantly differ from the i-GFR (45.6 ± 29.7). Of the subjects, 15 (17%) were normoalbuminuric. Their i-GFR did not differ from the albuminuric rate and from their MDRD e-GFR, although their serum creatinine was lower (122 ± 27 vs. 160 ± 71 μmol/l, P < 0.05): 71% would not have been detected by measuring serum creatinine (sCr) alone. They were less affected by diabetic retinopathy, and their HDL cholesterol and hemoglobin were higher (P < 0.05 vs. albuminuric). None of the CKD normoalbuminuric subjects started dialysis (microalbuminuric: 2/36, macroalbuminuric: 10/38) or died (microalbuminuric: 3/36, macroalbuminuric: 7/38) during the follow-up period (log-rank test: P < 0.005 for death or dialysis), and their albumin excretion rate and sCr values were stable after 38 months, whereas the AER increased in the microalbuminuric patients (P < 0.05), and the sCr increased in the macroalbuminuric patients (P < 0.01). CONCLUSIONS—Although their sCr is usually normal, most of the normoalbuminuric diabetic subjects with CKD according to an MDRD e-GFR below 60 ml/min per 1.73 m2 do really have a GFR below 60 ml/min per 1.73 m2. However, as expected, because of normoalbuminuria and other favorable characteristics, their risk for CKD progression or death is lower. |
| Author | Vincent Rigalleau Philippe Chauveau Nicole Barthe Catherine Lasseur Christelle Raffaitin Marie-Christine Beauvieux Henri Gin Christian Combe |
| Author_xml | – sequence: 1 givenname: Vincent surname: Rigalleau fullname: Rigalleau, Vincent organization: Department of Nutrition-Diabétologie, Hôpital Haut-Lévêque, Pessac, France – sequence: 2 givenname: Catherine surname: Lasseur fullname: Lasseur, Catherine organization: Department of Nephrologie, Université Victor Segalen-Bordeaux 2, Hôpital Pellegrin, Bordeaux, France – sequence: 3 givenname: Christelle surname: Raffaitin fullname: Raffaitin, Christelle organization: Department of Nutrition-Diabétologie, Hôpital Haut-Lévêque, Pessac, France – sequence: 4 givenname: Marie-Christine surname: Beauvieux fullname: Beauvieux, Marie-Christine organization: Department of Biochimie, Hôpital Haut-Lévêque, Pessac, France – sequence: 5 givenname: Nicole surname: Barthe fullname: Barthe, Nicole organization: Department of Médecine Nucléaire, Hôpital Pellegrin, Bordeaux, France – sequence: 6 givenname: Philippe surname: Chauveau fullname: Chauveau, Philippe organization: Department of Nephrologie, Université Victor Segalen-Bordeaux 2, Hôpital Pellegrin, Bordeaux, France – sequence: 7 givenname: Christian surname: Combe fullname: Combe, Christian organization: Department of Nephrologie, Université Victor Segalen-Bordeaux 2, Hôpital Pellegrin, Bordeaux, France – sequence: 8 givenname: Henri surname: Gin fullname: Gin, Henri organization: Department of Nutrition-Diabétologie, Hôpital Haut-Lévêque, Pessac, France |
| BookMark | eNptj0tLAzEUhYNU7EMX_oNuFcbmaZKl1FehqIiuw51MYiPTjCRTxH9vxroSV_dy7jmX803RKHbRIXRK8AVlTC4ai2WFCccHaEI0E5UQXI3QpEi6ElrTMZrm_I4x5lypIzQmkishJJ8g8dClbQdtvduGuEvBzp9dhLZaxbzzPtjgYj-_DlC7vtyeoB-EfIwOPbTZnfzOGXq9vXlZ3lfrx7vV8mpdWUowrqDmnDQEBFalJ-W6BpDMW8CXnhPQllrNwXovGk2lINYBraVjqnS23DM2Q2f7vzZ1OSfnzUcKW0hfhmAzoJsB3Qzoxbv447WhL3272CcI7b-J831iE942nyE50_yAujwsForAsFGGYsbZN2eKagU |
| CitedBy_id | crossref_primary_10_1155_2016_5374746 crossref_primary_10_4103_ijem_IJEM_225_20 crossref_primary_10_1016_j_dsx_2017_05_016 crossref_primary_10_1053_j_ajkd_2018_02_364 crossref_primary_10_1016_j_medcle_2021_01_008 crossref_primary_10_1111_1753_0407_12414 crossref_primary_10_1371_journal_pone_0116403 crossref_primary_10_1053_j_ajkd_2008_07_040 crossref_primary_10_1097_MD_0000000000003175 crossref_primary_10_1016_S1957_2557_12_70471_6 crossref_primary_10_1007_s40620_019_00650_x crossref_primary_10_1007_s13410_020_00819_2 crossref_primary_10_1159_000506634 crossref_primary_10_2478_jomb_2019_0026 crossref_primary_10_1016_j_diabres_2008_05_004 crossref_primary_10_1055_s_0042_1757718 crossref_primary_10_1007_s40520_024_02876_7 crossref_primary_10_1016_j_jdiacomp_2013_02_008 crossref_primary_10_3810_hp_2012_04_965 crossref_primary_10_1155_2020_8075376 crossref_primary_10_1007_s13300_025_01731_w crossref_primary_10_1186_s40001_021_00612_9 crossref_primary_10_2337_dc08_2325 crossref_primary_10_3390_jcm4091761 crossref_primary_10_1007_s10157_020_01935_3 crossref_primary_10_1016_j_diabet_2013_09_008 crossref_primary_10_1016_j_medcli_2021_01_007 crossref_primary_10_1007_s00125_018_4691_2 crossref_primary_10_1002_oby_23709 crossref_primary_10_1007_s00125_015_3548_1 crossref_primary_10_1186_1471_2369_11_3 crossref_primary_10_1007_s00125_017_4387_z crossref_primary_10_1016_j_jdiacomp_2016_03_020 crossref_primary_10_1016_j_jlr_2021_100120 crossref_primary_10_1186_s40364_015_0042_3 crossref_primary_10_1016_S1262_3636_11_70961_2 crossref_primary_10_1053_j_ajkd_2011_09_017 crossref_primary_10_2147_DMSO_S318972 crossref_primary_10_1007_s11684_017_0542_7 crossref_primary_10_1111_nep_12446 crossref_primary_10_2147_DMSO_S445341 crossref_primary_10_1002_dmrr_844 crossref_primary_10_1007_s00592_014_0650_7 crossref_primary_10_1007_s13340_012_0099_2 crossref_primary_10_2215_CJN_11511114 crossref_primary_10_2337_dc09_1098 crossref_primary_10_1089_dtom_2024_0008 crossref_primary_10_2337_dc21_1081 crossref_primary_10_1016_j_jdiacomp_2014_07_001 crossref_primary_10_3389_fphar_2021_759299 crossref_primary_10_1093_ndt_gfp475 crossref_primary_10_1016_S1957_2557_11_70054_2 crossref_primary_10_1016_j_jdiacomp_2012_10_010 crossref_primary_10_3810_pgm_2009_03_1980 crossref_primary_10_3389_fendo_2022_871272 crossref_primary_10_1097_MNH_0b013e32833e4ce1 crossref_primary_10_1007_s10157_013_0879_4 crossref_primary_10_1016_j_numecd_2019_07_017 crossref_primary_10_1007_s00125_017_4378_0 crossref_primary_10_3892_etm_2018_6319 crossref_primary_10_1016_j_jdiacomp_2012_09_010 crossref_primary_10_1007_s12291_018_0773_7 crossref_primary_10_2337_dc19_2049 crossref_primary_10_2337_dc19_0342 crossref_primary_10_1038_ki_2014_98 crossref_primary_10_1093_ndt_gft506 crossref_primary_10_1016_j_mcna_2012_10_006 crossref_primary_10_1097_MD_0000000000042635 crossref_primary_10_1136_bmjopen_2018_021655 crossref_primary_10_1093_ndt_gfn603 crossref_primary_10_3389_fendo_2021_761386 crossref_primary_10_1111_nep_12719 crossref_primary_10_34067_KID_0002152022 crossref_primary_10_1016_j_jdiacomp_2023_108403 crossref_primary_10_1007_s00125_012_2536_y crossref_primary_10_1007_s42399_025_01985_2 crossref_primary_10_1186_1471_2369_15_150 crossref_primary_10_1111_1753_0407_12148 crossref_primary_10_1053_j_ajkd_2013_01_005 crossref_primary_10_1097_XCE_0000000000000180 crossref_primary_10_2337_dc15_0641 crossref_primary_10_1016_j_diabres_2008_01_023 crossref_primary_10_3390_biomedicines9050457 crossref_primary_10_1111_j_1464_5491_2008_02592_x crossref_primary_10_3109_0886022X_2013_835266 crossref_primary_10_7759_cureus_27308 crossref_primary_10_1007_s10157_011_0508_z crossref_primary_10_1007_s10157_013_0870_0 crossref_primary_10_3390_endocrines3020016 crossref_primary_10_1016_j_jdiacomp_2018_09_019 crossref_primary_10_1016_j_diabet_2012_04_001 crossref_primary_10_1038_jhh_2008_115 |
| Cites_doi | 10.1093/ndt/gfl180 10.2337/dc05-2201 10.2337/diabetes.50.12.2842 10.2337/dc06-0248 10.2337/diacare.25.11.2026 10.2337/dc06-0940 10.1136/bmj.298.6672.487 10.1007/BF00404802 10.1681/ASN.2004080692 10.2337/diacare.26.8.2353 10.2337/diacare.19.2.171 10.1046/j.1523-1755.1999.07125.x 10.1038/sj.ki.5000061 10.1007/s00125-006-0247-y 10.2337/diacare.28.4.838 10.1210/jc.2004-0678 10.1681/ASN.2004070549 10.1136/bmj.295.6598.581-a 10.2337/diabetes.47.11.1786 10.1007/s001250050983 10.1016/j.metabol.2005.07.014 10.1681/ASN.2005060638 10.2337/diacare.26.5.1530 10.1001/jama.289.24.3273 10.1111/j.1523-1755.2004.00925.x 10.2337/dc06-0407 10.2337/diabetes.52.4.1036 10.1093/ndt/gfl649 10.2337/diacare.27.1.195 10.2337/diacare.28.7.1813 10.1681/ASN.2004060447 10.1093/ndt/gfi163 10.1093/ndt/gfh248 10.1053/j.ajkd.2006.06.011 10.7326/0003-4819-139-2-200307150-00013 10.2337/diabetes.43.5.649 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION |
| DOI | 10.2337/dc07-0140 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1935-5548 |
| EndPage | 2039 |
| ExternalDocumentID | 10_2337_dc07_0140 diacare_30_8_2034 |
| GroupedDBID | - 0R 1AW 29F 2WC 3V. 4.4 53G 55 5GY 5RE 5RS 5VS 7RV 7X2 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAIKC AASXA AAWTL AAYEP ABFLS ABOCM ABPPZ ABPTK ABUWG ACGOD ACJLH ACVYA ADACO ADBBV ADBIT AENEX AFDAS AFFNX AFKRA AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AN0 AQUVI ATCPS AZQEC BAWUL BBAFP BCR BCU BEC BENPR BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BVXVI C1A CS3 DIK DU5 DWQXO E3Z EBS EDB EJD ET EX3 F5P FYUFA GJ GNUQQ GUQSH GX1 H13 HCIFZ HZ IAG IAO IEA IGG IHR INH INR IOF IPO ITC J5H K9- KM KQ8 L7B M0K M0R M0T M1P M2O M2P M2Q M5 MBDVC O0- O9- OK1 OVD P2P PADUT PCD PEA PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q2X RHF RHI S0X SJFOW SV3 TDI TWZ WH7 WOQ WOW X7M XZ ZA5 --- -ET ..I .55 .GJ .XZ 08P 0R~ 18M 6PF AAFWJ AAKAS AAMNW AAYXX ACGFO ADZCM AEGXH AERZD AFFHD AIAGR BTFSW CCPQU CITATION EMOBN HMCUK HZ~ M5~ N4W NAPCQ PHGZM PHGZT PJZUB PPXIY TEORI TR2 UKHRP VVN W8F WHG YHG YOC ~KM |
| ID | FETCH-LOGICAL-c2100-ab441d1a508233249baa73fca06f41a9c2c94acff5d92751cea2b7e38599c4f33 |
| ISSN | 0149-5992 |
| IngestDate | Sat Nov 29 06:27:15 EST 2025 Tue Nov 18 22:33:09 EST 2025 Fri Jan 15 19:48:07 EST 2021 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c2100-ab441d1a508233249baa73fca06f41a9c2c94acff5d92751cea2b7e38599c4f33 |
| OpenAccessLink | https://diabetesjournals.org/care/article-pdf/30/8/2034/596856/zdc00807002034.pdf |
| PMID | 17485574 |
| PageCount | 6 |
| ParticipantIDs | crossref_primary_10_2337_dc07_0140 highwire_diabetes_diacare_30_8_2034 crossref_citationtrail_10_2337_dc07_0140 |
| ProviderPackageCode | RHF RHI |
| PublicationCentury | 2000 |
| PublicationDate | 20070801 2007-08-01 |
| PublicationDateYYYYMMDD | 2007-08-01 |
| PublicationDate_xml | – month: 08 year: 2007 text: 20070801 day: 01 |
| PublicationDecade | 2000 |
| PublicationTitle | Diabetes care |
| PublicationYear | 2007 |
| Publisher | American Diabetes Association |
| Publisher_xml | – name: American Diabetes Association |
| References | 2022031219245868400_R4 2022031219245868400_R24 2022031219245868400_R5 2022031219245868400_R25 2022031219245868400_R2 2022031219245868400_R26 2022031219245868400_R3 2022031219245868400_R27 2022031219245868400_R28 2022031219245868400_R1 2022031219245868400_R29 2022031219245868400_R40 2022031219245868400_R20 2022031219245868400_R21 2022031219245868400_R22 2022031219245868400_R23 2022031219245868400_R8 2022031219245868400_R9 2022031219245868400_R6 2022031219245868400_R7 2022031219245868400_R13 2022031219245868400_R35 2022031219245868400_R14 2022031219245868400_R36 2022031219245868400_R15 2022031219245868400_R37 2022031219245868400_R16 2022031219245868400_R38 2022031219245868400_R17 2022031219245868400_R39 2022031219245868400_R18 2022031219245868400_R19 2022031219245868400_R30 2022031219245868400_R31 2022031219245868400_R10 2022031219245868400_R32 2022031219245868400_R11 2022031219245868400_R33 2022031219245868400_R12 2022031219245868400_R34 |
| References_xml | – ident: 2022031219245868400_R19 doi: 10.1093/ndt/gfl180 – ident: 2022031219245868400_R31 doi: 10.2337/dc05-2201 – ident: 2022031219245868400_R25 doi: 10.2337/diabetes.50.12.2842 – ident: 2022031219245868400_R15 doi: 10.2337/dc06-0248 – ident: 2022031219245868400_R34 doi: 10.2337/diacare.25.11.2026 – ident: 2022031219245868400_R16 doi: 10.2337/dc06-0940 – ident: 2022031219245868400_R28 doi: 10.1136/bmj.298.6672.487 – ident: 2022031219245868400_R29 doi: 10.1007/BF00404802 – ident: 2022031219245868400_R2 – ident: 2022031219245868400_R23 doi: 10.1681/ASN.2004080692 – ident: 2022031219245868400_R33 doi: 10.2337/diacare.26.8.2353 – ident: 2022031219245868400_R40 doi: 10.2337/diacare.19.2.171 – ident: 2022031219245868400_R21 – ident: 2022031219245868400_R37 doi: 10.1046/j.1523-1755.1999.07125.x – ident: 2022031219245868400_R14 doi: 10.1038/sj.ki.5000061 – ident: 2022031219245868400_R35 doi: 10.1007/s00125-006-0247-y – ident: 2022031219245868400_R7 doi: 10.2337/diacare.28.4.838 – ident: 2022031219245868400_R22 – ident: 2022031219245868400_R26 doi: 10.1210/jc.2004-0678 – ident: 2022031219245868400_R17 doi: 10.1681/ASN.2004070549 – ident: 2022031219245868400_R36 doi: 10.1136/bmj.295.6598.581-a – ident: 2022031219245868400_R39 doi: 10.2337/diabetes.47.11.1786 – ident: 2022031219245868400_R1 doi: 10.1007/s001250050983 – ident: 2022031219245868400_R10 doi: 10.1016/j.metabol.2005.07.014 – ident: 2022031219245868400_R11 doi: 10.1681/ASN.2005060638 – ident: 2022031219245868400_R32 doi: 10.2337/diacare.26.5.1530 – ident: 2022031219245868400_R24 doi: 10.1001/jama.289.24.3273 – ident: 2022031219245868400_R38 doi: 10.1111/j.1523-1755.2004.00925.x – ident: 2022031219245868400_R9 doi: 10.2337/dc06-0407 – ident: 2022031219245868400_R4 doi: 10.2337/diabetes.52.4.1036 – ident: 2022031219245868400_R18 doi: 10.1093/ndt/gfl649 – ident: 2022031219245868400_R3 doi: 10.2337/diacare.27.1.195 – ident: 2022031219245868400_R6 doi: 10.2337/diacare.28.7.1813 – ident: 2022031219245868400_R8 doi: 10.1681/ASN.2004060447 – ident: 2022031219245868400_R12 doi: 10.1093/ndt/gfi163 – ident: 2022031219245868400_R27 doi: 10.1093/ndt/gfh248 – ident: 2022031219245868400_R13 doi: 10.1053/j.ajkd.2006.06.011 – ident: 2022031219245868400_R30 – ident: 2022031219245868400_R5 doi: 10.7326/0003-4819-139-2-200307150-00013 – ident: 2022031219245868400_R20 doi: 10.2337/diabetes.43.5.649 |
| SSID | ssj0004488 |
| Score | 1.8466245 |
| Snippet | Normoalbuminuric Renal-Insufficient Diabetic Patients
A lower-risk group
Vincent Rigalleau , MD, PHD 1 ,
Catherine Lasseur , MD 2 ,
Christelle Raffaitin , MD 1... OBJECTIVE—About 20% of diabetic patients with chronic kidney disease (CKD) detected from the new American Diabetes Association recommendations (albumin... |
| SourceID | crossref highwire |
| SourceType | Enrichment Source Index Database Publisher |
| StartPage | 2034 |
| Title | Normoalbuminuric Renal-Insufficient Diabetic Patients |
| URI | http://care.diabetesjournals.org/content/30/8/2034.abstract |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Agricultural Science Database customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: M0K dateStart: 19960701 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: M0R dateStart: 19960701 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: M0T dateStart: 19960701 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: 7RV dateStart: 19960701 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: BENPR dateStart: 19960701 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: 7X7 dateStart: 19960701 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: 8C1 dateStart: 19960701 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: M2O dateStart: 19960701 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1935-5548 dateEnd: 20130731 omitProxy: false ssIdentifier: ssj0004488 issn: 0149-5992 databaseCode: M2P dateStart: 19960701 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaWghAXxFMtjyoCDkgrQxLbsX1soQgkWKFqQb1FjuNIkUq66m6q_Un8TGbiOJvdcigHLlEUOVl7ZnY89nz-hpA3UpRCpllFs9Q4yrPM0ULJghotYDZVhqvKdsUm5Gymzs7098nkdzgLc3Uum0at13rxX1UNz0DZeHT2H9Q9fBQewD0oHa6gdrjeSPEziEIvOtRx3bQeJw_v0C_Nsu3oIjD573EwiIr3tKrLcYz6MWzHIiosKORn3SCOc3paY6remXaTvOiPEE6_Qhzu2gHs62kLMC8wPTWYNwok3568oHbUt8BXj-GDMEG3661NCDlA4FYj3D84pKGHu8YVdi81FdoXv3vnvMfVTFCIadTYJfepGm96auxfY7_1uev4U9ZRB5S2A9J6AqiRrhe_OmXD6ksJ4asCbVNv70yJA1AR_qMo65zFucrxx2-R26mEISBINJ5vTuDyrsLpMEDPYYW9ej_0Cflp-w5sB0GBmHoU2MwfkPv9iiQ68pb0kExc84jc_dZjLh4TsWtQ0XWDioJBRcGgnpAfn07mHz7TvtgGtbDqj6kpIDAuEyMw9QpRti6MkayyJs4qnhhtU6u5sVUlSg0SSKwzaSEdUzBcyyvGnpK95qJx-ySSWQmzli5YwgvOMmOSyjJXcCOlrWLDD8jbMPrc9kz0WBDlPIcVKcosR5nlKLMD8mpouvD0K39r9DqIMA8Zi_ya5p7dqNVzcm9j3y_I3uqydS_JHXu1qpeXh53S_wCxk4mZ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Normoalbuminuric+Renal-Insufficient+Diabetic+Patients&rft.jtitle=Diabetes+care&rft.au=Vincent+Rigalleau&rft.au=Catherine+Lasseur&rft.au=Christelle+Raffaitin&rft.au=Marie-Christine+Beauvieux&rft.date=2007-08-01&rft.pub=American+Diabetes+Association&rft.issn=0149-5992&rft.eissn=1935-5548&rft.volume=30&rft.issue=8&rft.spage=2034&rft_id=info:doi/10.2337%2Fdc07-0140&rft_id=info%3Apmid%2F17485574&rft.externalDBID=n%2Fa&rft.externalDocID=diacare_30_8_2034 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon |